Pcif1 knockout enhances the effects of anti-PD-1 treatment by decreasing TGF-β levels and increasing IFN-γ, TNF-α levels, and tumor-infiltrating natural killer cells via m6Am modifications (35). Here, PCIF1 is linked to neoplasm.